Levicept Limited
Effective and well-tolerated analgesia
- Headquarters
- Oxford
- Employees
- 1–10
- Business Model
- B2B
- Website
- levicept.com
About
Levicept Limited is a UK-based biotechnology company developing LEVI-04, a novel biological therapy for the treatment of chronic pain. LEVI-04 modulates the neurotrophin pathway via neurotrophin-3 and has successfully completed a Phase II clinical trial in patients with osteoarthritis of the knee. The therapy is designed to provide effective analgesia while minimising the use-limiting side effects associated with opiates and NSAIDs, addressing a critical unmet need for the more than one billion people worldwide living with chronic pain.
Summary
Levicept Limited is a Biotech company based in Oxford, United Kingdom.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/levicept-limited"><img src="https://indexed.vc/api/badge/company/levicept-limited" alt="Levicept Limited on Indexed.vc" width="260" height="76" /></a>